MedPath

黑龙江喜人药业集团有限公司

Ownership
-
Established
2011-01-19
Employees
-
Market Cap
-
Website
www.xirenjt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Vitamin E Nicotinicate Capsules

Product Name
维生素E烟酸酯胶囊
Approval Number
国药准字H23022812
Approval Date
Jun 12, 2023
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H23021613
Approval Date
Jun 12, 2023
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H23021530
Approval Date
Jun 12, 2023
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H23021295
Approval Date
Jun 12, 2023
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H23021525
Approval Date
Jun 1, 2023
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H23021528
Approval Date
Jun 1, 2023
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H23021526
Approval Date
Jun 1, 2023
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H23021529
Approval Date
Jun 1, 2023
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H23021527
Approval Date
Jun 1, 2023
NMPA

双黄连口服液

Approval Number
国药准字Z23021566
Approval Date
Jul 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.